Simultaneous silencing of A2aR and PD-1 as immune checkpoints by siRNA-loaded nanoparticles enhances the immunotherapeutic potential of dendritic cell vaccine in tumor experimental models

Life Sciences ◽  
2021 ◽  
pp. 120166
Author(s):  
Fariba Karoon Kiani ◽  
Sepideh Izadi ◽  
Ehsan Ansari Dezfouli ◽  
Farbod Ebrahimi ◽  
Mohammad Mohammadi ◽  
...  
Keyword(s):  
Dendritic Cell ◽  
Dendritic Cell Vaccine ◽  
Experimental Models ◽  
Immune Checkpoints ◽  
Cell Vaccine

Construction of PSA-specific dendritic cell vaccine and its in vitro immune activity

2009 ◽  
Vol 29 (3) ◽  
pp. 265-270
Author(s):  
Dan-feng XU ◽  
Yi GAO ◽  
Yu-shan LIU ◽  
Xin-gang CUI ◽  
Jian-ping CHE ◽  
...  
Keyword(s):  
Dendritic Cell ◽  
Dendritic Cell Vaccine ◽  
Cell Vaccine ◽  
Immune Activity

scholarly journals 423. The Combination of p53 Dendritic Cell Vaccine and Ad-p53 Gene Therapy Against p53 Overexpressing and p53 Deleted Tumor Cell Lines

2015 ◽  
Vol 23 ◽  
pp. S167
Author(s):  
Hiroki Saito ◽  
Koichi Kitagawa ◽  
Risa Yamasaki ◽  
Nami Katai ◽  
Naoya Morishita ◽  
...  
Keyword(s):  
Gene Therapy ◽  
Dendritic Cell ◽  
Tumor Cell ◽  
Cell Lines ◽  
P53 Gene ◽  
Dendritic Cell Vaccine ◽  
Cell Vaccine ◽  
Tumor Cell Lines

Single Injection of CD34+ Progenitor-Derived Dendritic Cell Vaccine Can Lead to Induction of T-Cell Immunity in Patients With Stage IV Melanoma

2003 ◽  
Vol 26 (5) ◽  
pp. 432-439 ◽  
Author(s):  
A. Karolina Palucka ◽  
Madhav V. Dhodapkar ◽  
Sophie Paczesny ◽  
Susan Burkeholder ◽  
Knut M. Wittkowski ◽  
...  
Keyword(s):  
T Cell ◽  
Dendritic Cell ◽  
Single Injection ◽  
Stage Iv ◽  
Dendritic Cell Vaccine ◽  
T Cell Immunity ◽  
Cell Vaccine ◽  
Cell Immunity ◽  
Stage Iv Melanoma

Portulaca oleracea L. polysaccharides enhance the immune efficacy of dendritic cell vaccine for breast cancer

2021 ◽  
Author(s):  
Guiyan Jia ◽  
Xingyue Shao ◽  
Rui Zhao ◽  
Tao Zhang ◽  
Xiechen Zhou ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Dendritic Cell ◽  
Signaling Pathway ◽  
Mechanism Of Action ◽  
Dendritic Cell Vaccine ◽  
Portulaca Oleracea ◽  
Cell Vaccine ◽  
Dc Vaccine ◽  
Immune Efficacy ◽  
Dc Maturation

POL-P3b, as a promising dietary adjuvant for the DC vaccine of breast cancer, could induce DC maturation and the mechanism of action involved in the TLR4/MyD88/NF-κB signaling pathway.

scholarly journals FRET microscopy autologous tumor lysate processing in mature dendritic cell vaccine therapy

2010 ◽  
Vol 8 (1) ◽  
pp. 52 ◽  
Author(s):  
Laura Fiammenghi ◽  
Valentina Ancarani ◽  
Tilman Rosales ◽  
Jay R Knutson ◽  
Massimiliano Petrini ◽  
...  
Keyword(s):  
Dendritic Cell ◽  
Dendritic Cell Vaccine ◽  
Vaccine Therapy ◽  
Cell Vaccine ◽  
Autologous Tumor ◽  
Mature Dendritic Cell ◽  
Tumor Lysate

PS17 - 86. Clinical grade dendritic cell vaccine to treat type 1 diabetes retain stable tolerogenic properties

2011 ◽  
Vol 9 (3) ◽  
pp. 150-150
Author(s):  
Tatjana Nikolic ◽  
Fleur S. Kleijwegt ◽  
Josefine Teeler ◽  
Sandra Laban ◽  
Antoinette M. Joosten ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Dendritic Cell ◽  
Dendritic Cell Vaccine ◽  
Cell Vaccine ◽  
Clinical Grade
Sign in / Sign up

Export Citation Format

Share Document